Literature DB >> 15591160

Hepatic triglyceride contents are genetically determined in mice: results of a strain survey.

Xiaobo Lin1, Pin Yue, Zhouji Chen, Gustav Schonfeld.   

Abstract

To assess whether genetic factor(s) determine liver triglyceride (TG) levels, a 10-mouse strain survey of liver TG contents was performed. Hepatic TG contents were highest in BALB/cByJ, medium in C57BL/6J, and lowest in SWR/J in both genders. Ninety and seventy-six percent of variance in hepatic TG in males and females, respectively, was due to strain (genetic) effects. To understand the physiological/biochemical basis for differences in hepatic TG among the three strains, studies were performed in males of the BALB/cByJ, C57BL/6J, and SWR/J strains. In vivo hepatic fatty acid (FA) synthesis rates and hepatic TG secretion rates ranked BALB/cByJ approximately C57BL/6J > SWR/J. Hepatic 1-(14)C-labeled palmitate oxidation rates and plasma beta-hydroxybutyrate concentrations ranked in reverse order: SWR/J > BALB/cByJ approximately C57BL/6J. After 14 h of fasting, plasma-free FA and hepatic TG contents rose most in BALB/cByJ and least in SWR/J. beta-Hydroxybutyrate concentrations rose least in BALB/cByJ and most in SWR/J. Adaptation to fasting was most effective in SWR/J and least in BALB/cByJ, perhaps because BALB/cByJ are known to be deficient in SCAD, a short-chain FA oxidizing enzyme. To assess the role of insulin action, glucose tolerance test (GTT) was performed. GTT-glucose levels ranked C57BL/6J > BALB/cByJ approximately SWR/J. Thus strain-dependent (genetic) factors play a major role in setting hepatic TG levels in mice. Processes such as FA production and hepatic export in VLDL on the one hand and FA oxidation on the other, explain some of the strain-related differences in hepatic TG contents. Additional factor(s) in the development of fatty liver in BALB/cByJ remain to be demonstrated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15591160     DOI: 10.1152/ajpgi.00411.2004

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  25 in total

1.  Long-term assessment of contrast effects of gadofluorine M and gadofluorine P in magnetic resonance imaging of mice.

Authors:  Fugeng Sheng; Yusuke Inoue; Shigeru Kiryu; Makoto Watanabe; Kuni Ohtomo
Journal:  Jpn J Radiol       Date:  2011-12-02       Impact factor: 2.374

2.  A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting.

Authors:  Sarah E Hugo; Lourdes Cruz-Garcia; Santhosh Karanth; Ryan M Anderson; Didier Y R Stainier; Amnon Schlegel
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

3.  Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice.

Authors:  Igor P Pogribny; Athena Starlard-Davenport; Volodymyr P Tryndyak; Tao Han; Sharon A Ross; Ivan Rusyn; Frederick A Beland
Journal:  Lab Invest       Date:  2010-06-14       Impact factor: 5.662

4.  Liver regeneration is impaired in lipodystrophic fatty liver dystrophy mice.

Authors:  Vered Gazit; Alexander Weymann; Eric Hartman; Brian N Finck; Paul W Hruz; Anatoly Tzekov; David A Rudnick
Journal:  Hepatology       Date:  2010-10-21       Impact factor: 17.425

5.  Sexual dimorphism in cardiac triacylglyceride dynamics in mice on long term caloric restriction.

Authors:  Natasha H Banke; Lin Yan; Kayla M Pound; Sunil Dhar; Heather Reinhardt; Mariana S De Lorenzo; Stephen F Vatner; E Douglas Lewandowski
Journal:  J Mol Cell Cardiol       Date:  2011-12-03       Impact factor: 5.000

6.  Genetic control of obesity, glucose homeostasis, dyslipidemia and fatty liver in a mouse model of diet-induced metabolic syndrome.

Authors:  D S Sinasac; J D Riordan; S H Spiezio; B S Yandell; C M Croniger; J H Nadeau
Journal:  Int J Obes (Lond)       Date:  2015-09-18       Impact factor: 5.095

7.  Fatty liver and insulin resistance: not always linked.

Authors:  Gustav Schonfeld; Pin Yue; Xiaobo Lin; Zhouji Chen
Journal:  Trans Am Clin Climatol Assoc       Date:  2008

8.  Hepatic overexpression of steroid sulfatase ameliorates mouse models of obesity and type 2 diabetes through sex-specific mechanisms.

Authors:  Mengxi Jiang; Jinhan He; Heidi Kucera; Nilesh W Gaikwad; Bin Zhang; Meishu Xu; Robert M O'Doherty; Kyle W Selcer; Wen Xie
Journal:  J Biol Chem       Date:  2014-02-04       Impact factor: 5.157

9.  Accelerated fatty acid oxidation in muscle averts fasting-induced hepatic steatosis in SJL/J mice.

Authors:  Hong-Ping Guan; Joseph L Goldstein; Michael S Brown; Guosheng Liang
Journal:  J Biol Chem       Date:  2009-07-06       Impact factor: 5.157

10.  DHA attenuates postprandial hyperlipidemia via activating PPARα in intestinal epithelial cells.

Authors:  Rino Kimura; Nobuyuki Takahashi; Shan Lin; Tsuyoshi Goto; Kaeko Murota; Rieko Nakata; Hiroyasu Inoue; Teruo Kawada
Journal:  J Lipid Res       Date:  2013-10-16       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.